Hutch News

Hutch News

Stories tagged 'Leukemia'

Health disparities may affect end-of-life experiences of minority blood cancer patients

A new study finds ethnic and racial minorities with leukemia or lymphoma are more likely to die in hospital, receive aggressive care in last weeks of life than white patients

Dec. 11, 2017 | By Rachel Tompa / Fred Hutch News Service

A new study of nearly 9,500 blood cancer patients revealed that racial and ethnic minority patients have a different experience at the end of their lives than do their white counterparts.

View story >


‘Remarkable’ distinctions in pediatric leukemia point toward improved treatment

Big new study in pediatric and young adult acute myeloid leukemia warns against ‘trickle-down therapeutics’

Dec. 11, 2017 | By Susan Keown / Fred Hutch News Service

Researchers found key differences between the molecular signatures of AML in patients of different ages: So why should we keep assuming that therapies developed for the elderly will work for the young?

View story >


KUOW profiles E. Donnall Thomas and his Nobel Prize-winning work on a once 'radical' cure for leukemia

Fred Hutch research in bone marrow transplantation helped establish Seattle's biotech industry

Nov. 13, 2017 | By Molly McElroy / Fred Hutch News Service

KUOW profiles E. Donnall Thomas and his Nobel Prize-winning work on a once 'radical' cure for leukemia

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 21, 2017

Dr. Mohamed Sorror and colleagues have developed a novel, online risk-assessment tool for patients with acute myeloid leukemia.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 14, 2017

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc. The exclusive, worldwide license, announced Sept. 14 by Mustang Bio, will allow a new type of CAR (chimeric antigen receptor) T-cell therapy to be tested in a clinical trial as a treatment for B-cell non-Hodgkin lymphomas. The novel immunotherapy targets CD20, a protein marker on cancer cells in lymphoma.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Aug. 17, 2017

Dr. Filippo Milano and colleagues in the Cord Blood Program at Fred Hutch have received funding from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation to support a clinical trial to improve the use of umbilical cord blood as a treatment for leukemia ... and more good news at Fred Hutch.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.